Empyrean Medical Systems partners with Thrive Pet Healthcare on Sirius veterinary radiation platform
Empyrean Medical Systems and Thrive Pet Healthcare announced a strategic partnership to bring the Sirius robotically accelerated conformal-beam radiation platform to veterinary oncology.

Evidence notes
- The first Sirius system is planned for PetCure Oncology at the Veterinary Specialty Center of Seattle, with the site expected to open in early 2026.
- Empyrean describes Sirius as a photon-augmented stereotactic radiation system that combines robotic precision, treatment planning, and real-time image guidance for targeted veterinary care.
Company overview
Empyrean Medical Systems develops radiation-oncology and research irradiation platforms. Its Morpheus system combines robot-assisted positioning, onboard tomosynthesis and treatment planning for intraoperative radiotherapy and brachytherapy. The enhanced Morpheus configuration remains FDA 510(k)-pending.